Our	In London	Your savings
Consultation	FREE	£75	100%
Dental Implant / from	£445	£1700	74%
Tooth Whitening	£460	£750	39%
X-Ray	FREE	£30	100%
Conscious Sedation	£250	£250	0%
Composite Filling	£60	£90	34%
Extraction	£46	£95	52%
Rootcanal Treatment	£100	£210	53%
Porcelain Veneer	£250	£500	50%
Porcelain Inlay	£200	£440	55%
Porcelain Crown	£320	£550	42%
Porcelain Fused to Gold	£250	£750	67%
Bridge units/tooth	£200	£550	64%
Denture with plastic tooth/arch	£345	£770	56%
Removable Metal Denture	£460	£950	52%

Contact Us & Price List
TreatmentCenter.co.uk news Dental Implant

MD Scientific Chooses Advocos to Help Promote EndoTool
Aug 22, 2006

Multi-year agreement signed.
Source: http://www.prweb.com/releases/2006/8/prweb427333.htm

Charlotte, NC (PRWEB) August 22, 2006 -- MD Scientific, LLC (MD Scientific), creators of EndoTool™, a software application to help healthcare providers calculate insulin dosage to control blood sugar for patients in critical care, announces a partnership with Advocos LLC, a contract sales organization that provides sales and marketing services to companies in the biotech and pharmaceutical industries.

EndoToolTM Glucose Management System received FDA clearance on June 20, 2006. The tool effectively and safely controls blood glucose for critically ill patients. Based upon over 32 proprietary algorithms, EndoTool™ provides patients with unique and individualized insulin dose calculations that rapidly control and maintain the patient's blood sugar. Advocos will work with MD Scientific to increase awareness of the EndoTool™ and to expand the use of the system throughout hospitals in their geographic area.

“Advocos understands the importance of a safe Tight Glycemic Control program in our hospitals,” said Shade Mecum, President of MD Scientific. “We are glad to continue our growth and to be working with Advocos in an effort to reduce infection rates in our hospital’s intensive care units through the use of the sophisticated EndoTool™ Glucose Management System.”

Robert Godfrey, President of Advocos LLC, said, "Our background in the hospital sector will give us the ability to quickly launch the EndoTool™, and to be able to impact the market significantly. We are looking forward to working with MD Scientific to increase the use of the dynamic EndoTool™ within hospitals.”

MD Scientific signed a multi-year agreement with Advocos. The contract will provide MD Scientific with multiple sales teams that will be launched in August and October 2006. The potential to expand these sales teams over time will increase MD Scientific’s EndoTool™ distribution and support.

About MD SCIENTIFIC
Founded in September 2003, MD Scientific has developed a software application to calculate insulin dosage for critically ill patients with elevated blood glucose and to control blood glucose levels. For more information about the company, EndoTool and other offerings, please visit www.mdscientific.com.

###